EUCTR2006-000859-18-CZ进行中（未招募）不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Subjects who have signed informed consent for participation in the extension study.
- •- Subjects who have completed the S308.3.003 trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subjects with medically relevant abnormal findings (electrocardiogram [ECG], physical examination, AEs) at end of the maintenance phase (Visit M6, Week 24) of study S308.3.003.
研究者
相似试验
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.002 in patients with Parkinson’s disease experiencing motor fluctuations. - An extension of the Mondrian studyAdvanced stage Parkinson's disease with motor fluctuations.MedDRA version: 9.1Level: LLTClassification code 10013113Term: Disease Parkinson'sEUCTR2006-005183-91-LTSolvay Pharmaceuticals220
进行中（未招募）
1 期
An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt studyParkinson's Disease Early StageEUCTR2006-000858-45-SKSolvay Pharmaceuticals300
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stageEUCTR2006-000859-18-NLSolvay pharmaceuticals247
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.001 in early PD patients. - An extension of the Rembrandt studyParkinson's Disease Early StageEUCTR2006-000858-45-SESolvay Pharmaceuticals300
进行中（未招募）
不适用
An open label SLV308 safety extension to study S308.3.003 in early PD patients - An extension to the Vermeer studyParkinson's Disease Early stageEUCTR2006-000859-18-DESolvay pharmaceuticals225